Unlike MEG3, another novel lncRNA GLCC1 was shown to protect c-Myc from degradation through ubiquitination, and this oncogenic lncRNA was associated with poor CRC prognoses [26]. The gene discussed is MEG3; the disease is colorectal carcinoma.